Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center-Reference-Cited by-同舟云学术

Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center

Published:2014-12-18 Issue:2 Volume:13 Page:293-302
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Benhamou Y.¹²³,Boelle P.-Y.⁴⁵,Baudin B.⁵⁶,Ederhy S.⁵⁷,Gras J.⁸,Galicier L.³⁹¹⁰,Azoulay E.³¹⁰¹¹,Provôt F.³¹²,Maury E.³⁵¹³,Pène F.³¹⁴¹⁵,Mira J.-P.³¹⁴¹⁵,Wynckel A.³¹⁶,Presne C.³¹⁷,Poullin P.³¹⁸,Halimi J.-M.³¹⁹²⁰,Delmas Y.³²¹,Kanouni T.³²²,Seguin A.³²³,Mousson C.³²⁴,Servais A.³²⁵,Bordessoule D.³²⁶,Perez P.³²⁷,Hamidou M.³²⁸,Cohen A.⁵⁷,Veyradier A.³²⁹³⁰,Coppo P.³⁸³¹

Affiliation:

1. Service de Médecine Interne; CHU Charles Nicolle; Rouen France

2. Inserm U1096; Rouen France

3. Centre de Référence des Microangiopathies Thrombotiques; Hôpital Saint-Antoine; AP-HP; Paris France

4. Faculté de Médecine Saint-Antoine; Inserm U707; Paris France

5. UPMC Univ. Paris 06; Sorbonne Université; Paris France

6. Service de Biochimie; Hôpital Saint-Antoine; AP-HP, Université Paris-Sud; Paris France

7. Service de Cardiologie; Hôpital Saint-Antoine; AP-HP; Paris France

8. Service d'Hématologie; Hôpital Saint-Antoine; AP-HP; Paris France

9. Service d'Immunologie Clinique; Hôpital Saint-Louis; AP-HP; Paris France

10. Sorbonne Paris Cité; Univ. Paris Diderot; Paris France

11. Service de Réanimation Médicale; Hôpital Saint-Louis; AP-HP; Paris France

12. Service de Néphrologie; Hôpital Albert Calmette; Lille France

13. Service de Réanimation Médicale; CHU Saint-Antoine; AP-HP; Paris France

14. Service de Réanimation Polyvalente; Hôpital Cochin; AP-HP; Paris France

15. Université Paris 5; Paris France

16. Service de Néphrologie; Hôpital Maison Blanche; Reims France

17. Service de Néphrologie - Médecine Interne; Hôpital Sud; Amiens France

18. Service d'Hémaphérèse; Hôpital de Marseille Conception; Marseille France

19. Service de néphrologie-immunologie clinique; Hôpital Bretonneau; Tours France

20. EA 4245; Université François-Rabelais; Tours France

21. Service de Néphrologie Transplantation Dialyse; Centre Hospitalier Universitaire; Bordeaux France

22. Unité d'Hémaphérèse thérapeutique; CHU de Montpellier; Montpellier France

23. Service de Réanimation Médicale; Centre Hospitalier Universitaire de Caen; Caen France

24. Service de Néphrologie; CHU de Dijon; Dijon France

25. Service de Néphrologie; Hôpital Necker-Enfants Malades; AP-HP; Paris France

26. Service d'Hématologie Clinique et de Thérapie Cellulaire; CHU Dupuytren; Limoges France

27. Service de Réanimation; CHU Brabois; Nancy France

28. Service Médecine Interne A; Hôpital Hôtel-Dieu; Nantes France

29. Service d'Hématologie Biologique; Hôpital Antoine Béclère; AP-HP; Paris France

30. Université Paris-Sud 11; Paris France

31. Inserm U1009; Institut Gustave Roussy; Villejuif France

Funder

Bayer Healthcare

MSD and Pfizer

INSERM and the Société de Réanimation de Langue Française

RESICARD

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12790/fullpdf

Reference35 articles.

1. Thrombotic microangiopathies: towards a pathophysiology-based classification;Coppo;Cardiovasc Hematol Disord Drug Targets,2009

2. Autoimmune thrombotic microangiopathy: advances in pathogenesis, diagnosis, and management;Tsai;Semin Thromb Hemost,2012

3. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura;Scully;Blood,2011

4. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center;Froissart;Crit Care Med,2012

5. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura;Rock;N Engl J Med,1991

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey;Blood Coagulation & Fibrinolysis;2024-07-24

2. Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpura;Research and Practice in Thrombosis and Haemostasis;2024-07

3. IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES.;Mediterranean Journal of Hematology and Infectious Diseases;2024-06-29

4. Reduction of mortality, cardiac damage, and cerebral damage by IL-1 inhibition in a murine model of TTP;Blood;2024-06-27

5. Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons;Expert Review of Hematology;2024-02-20